Exploring the transformability of polymer-lipid hybrid nanoparticles and nanomaterial-biology interplay to facilitate tumor penetration, cellular uptake and intracellular targeting of anticancer drugs

References

• Shi J, Kantoff PW, Wooster R, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37.
   PubMed Web of Science ®Google Scholar
• Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs. Annu Rev Med. 2012;63(1):185–198.
   PubMed Web of Science ®Google Scholar
• Zhang RX, Ahmed T, Li LY, et al. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks. Nanoscale. 2017;9(4): 1334–1355.
   PubMed Web of Science ®Google Scholar
• Zhang RX, Wong HL, Xue HY, et al. Nanomedicine of synergistic drug combinations for cancer therapy - strategies and perspectives. J Control Release. 2016;240:489–503.
   PubMed Web of Science ®Google Scholar
• Spencer DS, Puranik AS, Peppas NA. Intelligent nanoparticles for advanced drug delivery in cancer treatment. Curr Opin Chem Eng. 2015;7:84–92.
   PubMed Web of Science ®Google Scholar
• Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14(1):1–16.
   PubMedGoogle Scholar
• Yoo JW, Irvine DJ, Discher DE, et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat Rev Drug Discov. 2011;10(7):521–535.
   PubMed Web of Science ®Google Scholar
• Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014;9(2):223–243.
   PubMed Web of Science ®Google Scholar
• Wilhelm S, Tavares AJ, Dai Q, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1(5):16014.
   Web of Science ®Google Scholar
• Wang J, Byrne JD, Napier ME, et al. More effective nanomedicines through particle design. Small. 2011;7(14):1919–1931.
   PubMed Web of Science ®Google Scholar
• Kinnear C, Moore TL, Rodriguez-Lorenzo L, et al. Form follows function: nanoparticle shape and its implications for nanomedicine. Chem Rev. 2017;117(17):11476–11521.
   PubMed Web of Science ®Google Scholar
• Anselmo AC, Mitragotri S. Impact of particle elasticity on particle-based drug delivery systems. Adv Drug Deliv Rev. 2017 1;Jan(108):51–67.
   Google Scholar
• Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–951.
   PubMed Web of Science ®Google Scholar
• Cabral H, Matsumoto Y, Mizuno K, et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat Nanotechnol. 2011;6(12):815–823.
   PubMed Web of Science ®Google Scholar
• Duan X, Li Y. Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and trafficking. Small. 2013;9(9–10):1521–1532.
   PubMed Web of Science ®Google Scholar
• Sawant RR, Torchilin VP. Challenges in development of targeted liposomal therapeutics. Aaps J. 2012;14(2):303–315.
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013 Jan;65(1):36–48.
   PubMed Web of Science ®Google Scholar
• Gustafson HH, Holt-Casper D, Grainger DW, et al. Nanoparticle uptake: the phagocyte problem. Nano Today. 2015;10(4):487–510.
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Lahann J. Physical approaches to biomaterial design. Nat Mater. 2009;8(1):15–23.
   PubMed Web of Science ®Google Scholar
• Yoo JW, Doshi N, Mitragotri S. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery. Adv Drug Deliv Rev. 2011;63(14–15):1247–1256.
   PubMed Web of Science ®Google Scholar
• Da Silva-Candal A, Brown T, Krishnan V, et al. Shape effect in active targeting of nanoparticles to inflamed cerebral endothelium under static and flow conditions. J Control Release. 2019 Sep;10(309):94–105.
   Google Scholar
• Yoo J-W MS, Mitragotri S. Polymer particles that switch shape in response to a stimulus. Proc Natl Acad Sci U S A. 2010;107(25):11205–11210.
   PubMed Web of Science ®Google Scholar
• Hwang DK, Oakey J, Toner M, et al. Stop-flow lithography for the production of shape-evolving degradable microgel particles. J Am Chem Soc. 2009;131(12):4499–4504.
   PubMed Web of Science ®Google Scholar
• Chien M-P, Rush AM, Thompson MP, et al. Programmable shape-shifting micelles. Angew Chem (Int Ed in English). 2010;49(30):5076–5080.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, et al. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev. 2007;59(6):491–504.
   PubMed Web of Science ®Google Scholar
• Wu XY. Strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery. Expert Opin Drug Deliv. 2016;13(5):609–612.
   PubMed Web of Science ®Google Scholar
• Zhang RX, Li J, Zhang T, et al. Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples. Acta Pharmacol Sin. 2018 May;39(5):825–844.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, et al. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J Pharmacol Exp Ther. 2006;317(3):1372–1381.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, et al. Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers. J Pharm Sci. 2004 Aug;93(8):1993–2008.
   PubMed Web of Science ®Google Scholar
• Wong HL, Rauth AM, Bendayan R, et al. A new polymer-lipid hybrid nanoparticle system increases cytotoxicity of doxorubicin against multidrug-resistant human breast cancer cells. Pharm Res. 2006;23(7):1574–1585.
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, et al. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer. J Control Release. 2006;116(3):275–284.
   PubMed Web of Science ®Google Scholar
• Prasad P, Cheng J, Shuhendler A, et al. A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells. Drug Deliv Transl Res. 2012;2(2):95–105.
   PubMed Web of Science ®Google Scholar
• Prasad P, Shuhendler A, Cai P, et al. Doxorubicin and mitomycin C co-loaded polymer-lipid hybrid nanoparticles inhibit growth of sensitive and multidrug resistant human mammary tumor xenografts. Cancer Lett. 2013;334(2):263–273.
   PubMed Web of Science ®Google Scholar
• Zhang T, Prasad P, Cai P, et al. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice. Acta Pharmacol Sin. 2017;38(6):835–847.
   PubMed Web of Science ®Google Scholar
• Shuhendler AJ, Prasad P, Zhang RX, et al. Synergistic nanoparticulate drug combination overcomes multidrug resistance, increases efficacy, and reduces cardiotoxicity in a nonimmunocompromised breast tumor model. Mol Pharm. 2014;11(8):2659–2674.
   PubMedGoogle Scholar
• Zhang RX, Cai P, Zhang T, et al. Polymer-lipid hybrid nanoparticles synchronize pharmacokinetics of co-encapsulated doxorubicin-mitomycin C and enable their spatiotemporal co-delivery and local bioavailability in breast tumor. Nanomedicine. 2016 Jul;12(5):1279–1290.
   PubMed Web of Science ®Google Scholar
• Xiong XB, Mahmud A, Uludag H, et al. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells. Pharm Res. 2008 Nov;25(11):2555–2566.
   PubMed Web of Science ®Google Scholar
• Baguley BC. Multiple drug resistance mechanisms in cancer. Mol Biotechnol. 2010 Nov;46(3):308–316.
   PubMed Web of Science ®Google Scholar
• Ozben T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 2006 May 22;580(12):2903–2909.
   PubMed Web of Science ®Google Scholar
• Alshareeda AT, Rakha EA, Nolan CC, et al. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer. Breast Cancer Res Treat. 2012;134(2):519–529.
   PubMed Web of Science ®Google Scholar
• Smathers RL, Petersen DR. The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics. 2011 Mar;5(3):170–191.
   PubMedGoogle Scholar
• Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008;7(6):489–503.
   PubMed Web of Science ®Google Scholar
• Zhang RX, Li LY, Li J, et al. Coordinating biointeraction and bioreaction of a nanocarrier material and an anticancer drug to overcome membrane rigidity and target mitochondria in multidrug-resistant cancer cells. Adv Funct Mater. 2017;27(39):1700804.
   Web of Science ®Google Scholar
• Abdekhodaie MJ, Liu Z, Erhan SZ, et al. Characterization of novel soybean-oil-based thermosensitive amphiphilic polymers for drug delivery applications. Poly Int. 2012;61(9):1477–1484.
   Web of Science ®Google Scholar
• Wong HL, Rauth AM, Bendayan R, et al. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Eur J Pharm Biopharm. 2007 Mar;65(3):300–308.
   PubMed Web of Science ®Google Scholar
• Fan HY, Raval G, Shalviri A, et al. Coupled equilibria of a self-associating drug loaded into polymeric nanoparticles. Methods. 2015;76:162–170.
   PubMed Web of Science ®Google Scholar
• Li J, Chu MK, Lu B, et al. Enhancing thermal stability of a highly concentrated insulin formulation with Pluronic F-127 for long-term use in microfabricated implantable devices. Drug Deliv Transl Res. 2017 Aug;7(4):529–543.
   PubMed Web of Science ®Google Scholar
• GhavamiNejad A, Lu B, Samarikhalaj M, et al. Transdermal delivery of a somatostatin receptor type 2 antagonist using microneedle patch technology for hypoglycemia prevention. In: Drug Delivery Transl Res (In Press). 2021. https://doi.org/10.1007/s13346-021-00944-3.
   Google Scholar
• Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 2006;6(4):662–668.
   PubMed Web of Science ®Google Scholar
• Chithrani BD, Chan WCW. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007;7(6):1542–1550.
   PubMed Web of Science ®Google Scholar
• Barua S, Yoo J-W, Kolhar P, et al. Particle shape enhances specificity of antibody-displaying nanoparticles. Proc Nat Acad Sci. 2013;110(9):3270–3275.
   PubMed Web of Science ®Google Scholar
• Ahmed T, Kamel AO, Wettig SD. Interactions between DNA and Gemini surfactant: impact on gene therapy: part I. Nanomedicine (Lond). 2016 Feb;11(3):289–306.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang RX, Zhang T, et al. In situ proapoptotic peptide-generating rapeseed protein-based nanocomplexes synergize chemotherapy for Cathepsin-B overexpressing breast cancer. ACS Appl Mater Interfaces. 2018 Dec 5;10(48):41056–41069.
   PubMed Web of Science ®Google Scholar
• Shalviri A, Cai P, Rauth AM, et al. Evaluation of new bi-functional terpolymeric nanoparticles for simultaneous in vivo optical imaging and chemotherapy of breast cancer. Drug Deliv Transl Res. 2012;2(6):437–453.
   PubMed Web of Science ®Google Scholar
• Shalviri A, Chan HK, Raval G, et al. Design of pH-responsive nanoparticles of terpolymer of poly(methacrylic acid), polysorbate 80 and starch for delivery of doxorubicin. Colloids Surf B Biointerfaces. 2013;101:405–413.
   PubMed Web of Science ®Google Scholar
• Behzadi S, Serpooshan V, Tao W, et al. Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev. 2017 Jul 17;46(14):4218–4244.
   PubMed Web of Science ®Google Scholar
• Rejman J, Oberle V, Zuhorn IS, et al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J. 2004;377(Pt 1):159–169.
   PubMed Web of Science ®Google Scholar
• Chamberlain GR, Tulumello DV, Kelley SO. Targeted delivery of doxorubicin to mitochondria. ACS Chem Biol. 2013;8(7):1389–1395.
   PubMed Web of Science ®Google Scholar
• Dunn KW, Kamocka MM, McDonald JH. A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol. 2011;300(4):C723–42.
   PubMed Web of Science ®Google Scholar
• Fard JK, Hamzeiy H, Sattari M, et al. Triazole rizatriptan induces liver toxicity through lysosomal/mitochondrial dysfunction. Drug Res (Stuttg). 2016 Sep;66(9):470–478.
   PubMed Web of Science ®Google Scholar
• Eftekhari A, Maleki Dizaj S, Sharifi S, et al. The use of nanomaterials in tissue engineering for cartilage regeneration; current approaches and future perspectives. In Int J Mol Sci. Vol. 21. Jan 14. 2020;21(2):536.  https://doi.org/10.3390/ijms21020536.
   Google Scholar
• Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012;148(6):1145–1159.
   PubMed Web of Science ®Google Scholar